Your browser doesn't support javascript.
loading
Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency.
Duréault, Amélie; Tcherakian, Colas; Poiree, Sylvain; Catherinot, Emilie; Danion, François; Jouvion, Grégory; Bougnoux, Marie Elisabeth; Mahlaoui, Nizar; Givel, Claire; Castelle, Martin; Picard, Capucine; Chansdesris, Marie Olivia; Lortholary, Olivier; Lanternier, Fanny.
Afiliação
  • Duréault A; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Université Paris Descartes, Paris, France.
  • Tcherakian C; Service de Pneumologie, Hôpital Foch, Suresnes, France; Faculté des Sciences de la Santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France; National Referral Center for Hypereosinophilic (CEREO).
  • Poiree S; Service de Radiologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Catherinot E; Service de Pneumologie, Hôpital Foch, Suresnes, France; Faculté des Sciences de la Santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
  • Danion F; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Université Paris Descartes, Paris, France.
  • Jouvion G; Unité de Neuropathologie Expérimentale, Institut Pasteur, Paris, France; Département de Génétique Médicale, Hôpital Trousseau, Sorbonne Université, APHP, Paris, France.
  • Bougnoux ME; Service de Microbiologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Mahlaoui N; Centre d'Etude des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants Malades, APHP, Paris, France; CEREDIH, Centre de Référence des Déficits Immunitaires Héréditaires, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France; Service Immunologie-Hématologie Pédiatrique, Hôpital Necker-En
  • Givel C; Service de Pneumologie, Hôpital Foch, Suresnes, France; Faculté des Sciences de la Santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
  • Castelle M; Service d'Hématologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Picard C; Centre d'Etude des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants Malades, APHP, Paris, France; CEREDIH, Centre de Référence des Déficits Immunitaires Héréditaires, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France; Service Immunologie-Hématologie Pédiatrique, Hôpital Necker-En
  • Chansdesris MO; Service d'Hématologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.
  • Lortholary O; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Université Paris Descartes, Paris, France; Institut Pasteur, CNRS, Centre National de Référence Mycoses Invasives et Antifongiques, Unité de Mycologie Moléculaire, Paris, Fra
  • Lanternier F; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Université Paris Descartes, Paris, France; Institut Pasteur, CNRS, Centre National de Référence Mycoses Invasives et Antifongiques, Unité de Mycologie Moléculaire, Paris, Fra
J Allergy Clin Immunol Pract ; 7(6): 1986-1995.e3, 2019.
Article em En | MEDLINE | ID: mdl-30878710
ABSTRACT

BACKGROUND:

Autosomal-dominant signal transducer and activator of transcription 3 (STAT3) deficiency predisposes to recurrent bacterial pneumonia, complicated by bronchiectasis and cavitations. Aspergillosis is a major cause of morbidity in these patients. However, its diagnosis, classification, and treatment are challenging.

OBJECTIVE:

We aimed to assess the prevalence and describe the clinical, mycological, and radiological presentation and related therapy and outcome of Aspergillus infections of the respiratory tract in the STAT3-deficient patients of the National French cohort.

METHODS:

We performed a retrospective study of all pulmonary aspergillosis cases in STAT3-deficient patients (n = 74). Clinical and mycological data were collected up to October 2015 and imaging was centralized.

RESULTS:

Twenty-one episodes of pulmonary aspergillosis in 13 (17.5%) STAT3-deficient patients were identified. The median age at first episode was 13 years (interquartile range, 10-26 years). Ninety percent of patients had previous bronchiectasis or cavitations. Infections were classified as follows 5 single aspergilloma, 9 chronic cavity pulmonary aspergillosis, 5 allergic bronchopulmonary aspergillosis-like disease, and 2 mixed forms of concomitant allergic bronchopulmonary aspergillosis-like disease and chronic cavity pulmonary aspergillosis. No invasive aspergillosis cases were identified. Aspergillus species were isolated in 71% of episodes and anti-Aspergillus antibodies in 93%. Eleven episodes were breakthrough infections. Antifungal treatment was prolonged, with a median of 13 months, and 6 patients (7 episodes) required surgery, with a high rate of postsurgical complications. One patient died and 6 had a relapse.

CONCLUSIONS:

Chronic and allergic forms of aspergillosis occurred in 17.5% of STAT3-deficient patients, mostly in lung cavities. Almost half had recurrences, despite prolonged antifungal treatment and/or surgery.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Transcrição STAT3 / Aspergilose Pulmonar / Síndrome de Job Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Transcrição STAT3 / Aspergilose Pulmonar / Síndrome de Job Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França